Peter Yu

AI Observations in Oncology: Why Avoiding Emergent Technology Isn’t the Move | ASCO Connection And Finding the "art" in Artificial Intelligence connection.asco.org/do/ai-observat… @Hartford_Health @JCOCCI_ASCO @CI4CC

I’m here at MSK with Ani Offodile MSK Chief Strategy Officer celebrating Hartford HealthCare Cancer Institute at St Vincent’s Medical Center becoming today the first MSK Care Partner site @HartfordHealthC

Presenting on cancer data at the Association of Cancer Executives in Nashville. Loved this inspiring quote ⁦@HartfordHealthC⁩

Andrew Epstein and MSK colleagues publish in JCO CCI on the use of patient portals to elicit patient communication preferences, personal values and understanding of their cancer prognosis. #JCOCCI ascopubs.org/doi/abs/10.120…

What phase 3 trials garner the most social media interest? #jcocci JCO CCI paper describes what factors drive higher Altmetric scores. urldefense.com/v3/__https://a…

Antibody conjugated with light activated payload causing cellular disruption. Approved in a Japan for H&N cancer. Rakuten Medical. Trials of n US Taiwan and India #ASCOBT2023#HHC

Keynote speaker Hiroshi Mikitani Rakuten being introduced #ASCOBT23 by Dr Lillian Siu at Yokohama

@ASCO @GlopesMd Opening session with ASCO President Lynn Schuchter. Strong support for global oncologists and a beautiful venue at Yokohama. Thanks to JSCO and JSMO

At #ASCOBT23, we’re bringing together experts from around the world to explore the latest topics in cancer care – like #artificialintelligence, #CRISPR, and more! Register today to join us online or in Yokohama: fal.cn/3AeGj @YupOnc #MedTech #HealthAI #OncTwitter

ASCO’s JCO Clinical Cancer Informatics received its initial impact factor of 4.2. Congratulations to immediate past Editor Debra Patt and incoming Editor Jeremy Warner #asco

I’m honored to serve as Co-Host Committee Chair for ASCO Breakthrough Yokohama Japan August 3-5, 2023 as an annual event bringing together international innovators in biotech, computational science and other fields that are at the cutting edge of cancer breakthroughs. #ASCOBT23

Hartford HealthCare is recruiting fellows and mid-career medical oncologists to join our hybrid academic-community cancer center. GU, GI, breast and general medical oncology. Exceptional opportunities for professional growth and leadership careercenter.asco.org/job/7613269/ha…

Real world implementation of geriatric oncology at #ASCOQLTY21 @ASCO by Dr Rawad Elias @OncElias. Delivering care with the resources already available to you in a sustainable manner

Warren Kibbe and I have edited a special series published today in JCO CCI on computational medicine and cancer medicine #DataScience and #computationalmedicine. My ASCO blog on this is at connection.asco.org/blogs/prepared…. @ASCO @YupOnc @HartfordHealthC @ADesaiMD

Armin Shahrokni eRFA tool predicts surgical mortality #CASH19 @YupOnc @OncElias

MSK leadership under Beatriz Korc-Grodzicki William Tew Armin Shahrokni Stu Lichtman and others CARG chemotherapy toxicity prediction tool leads to better shared decision making CASH19 @YupOnc @OncElias

Geriatrics Chemotherapy and comprehensive assessment has its roots with David Karnofsky KPS. Personalized medicine and patient centric aspects advanced with Jimmie Holland and Artie Hurria. MSK leadership continues today #CASH19 @YupOnc @OncElias

Mary Kate Eanniello nurse educator’s team sent to NCI sponsored team building program. Joined IHI 4M framework on what matters to patients #CASH19 @YupOnc @Eliasonc

Sincere McMillan from MSK on nursing education for geriatric oncology @YupOnc @eliasonc #CASH19

Dr Rawad Elias electronic fitness assessment #CASH19 @YupOnc

MSKCC and Hartford HealthCare inaugural Geriatric Oncology Symposium at Hartford